Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Aug 26, 2025
- Accession no.
- 0000097745-25-000108
- Filed
- Aug 26, 2025
- Trade date
- Aug 22, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.01M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $253.99 | +$2,539,900 | 125,173.62 | Direct | |
| Aug 22, 2025 | Common Stock | SSaleDisposed | −5,823 | $500.40 | −$2,913,829.2 | 119,350.62 | Direct | |
| Aug 22, 2025 | Common Stock | SSaleDisposed | −3,579 | $501.65 | −$1,795,405.35 | 115,771.62 | Direct | |
| Aug 22, 2025 | Common Stock | SSaleDisposed | −598 | $502.26 | −$300,351.48 | 115,173.62 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 24,754 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.